Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
496
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
-220K
-
Total reported value, excl. options
-
$12.5B
-
Value change
-
-$120M
-
Put/Call ratio
-
1.96
-
Number of buys
-
245
-
Number of sells
-
-207
-
Price
-
$644.29
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2021
551 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2021.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 496 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.28M shares), BlackRock Inc. (1.84M shares), FMR LLC (1.61M shares), STATE STREET CORP (974K shares), BROWN ADVISORY INC (569K shares), ALLIANCEBERNSTEIN L.P. (524K shares), MARSHALL WACE, LLP (435K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (406K shares), BANK OF AMERICA CORP /DE/ (398K shares), and GEODE CAPITAL MANAGEMENT, LLC (391K shares).
This table shows the top 496 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.